Three different patterns of CD4 recovery in a cohort of Chinese HIV patients following antiretroviral therapy – a five-year observational study

International Journal of STD and AIDS

Volumn 26, Issue 11, 2015, Pages 803-809

  Naftalin, Claire M ^a   Wong, Ngai Sze ^a   Chan, Denise PC ^a   Wong, Ka Hing ^b   Reidpath, Daniel D ^c   Lee, Shui Shan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Gov Hong Kong Special Admin Region   (China)

^c MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

AIDS; antiretroviral therapy; Asia; CD4 count; HAART; HIV; immunological response; treatment

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL FUNCTION; CHINESE; COHORT ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PATTERN RECOGNITION; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS LOAD; VIRUS TRANSMISSION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DRUG EFFECTS; EPIDEMIOLOGY; ETHNOLOGY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIAN CONTINENTAL ANCESTRY GROUP; CD4 LYMPHOCYTE COUNT; CHINA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84942094906     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462414553826     Document Type: Article

References (26)

1. J.ReekieC.KosaF.Engsig. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer2010; 116: 5306–5315.
2. N.G.PakkerD.W.NotermansR.J.de Boer. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med1998; 4: 208–214.
3. M.EggerM.MayG.Chêne. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet2002; 360: 119–129.
4. J.V.BakerG.PengJ.Rapkin. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS2008; 22: 841–848.
5. J.Van GriensvenS.Thai. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg2011; 105: 694–703.
6. G.R.KaufmannL.PerrinG.Pantaleo. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med2003; 163: 2187–2195.
7. R.D.MooreJ.C.Keruly. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis2007; 44: 441–446.
8. C.F.KelleyC.M.KitchenP.W.Hunt. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis2009; 48: 787–794.
9. G.R.KaufmannH.FurrerB.Ledergerber. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis2005; 41: 361–372.
10. X.LiJ.B.MargolickB.D.Jamieson. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy. J Acquir Immune Defic Syndr2011; 57: 421–428.
11. M.BastardK.SoulinphumyP.Phimmasone. Women experience a better long-term immune recovery and a better survival on HAART in Lao People’s Democratic Republic. BMC Infect Dis2013; 13: 27–27.
12. P.M.TarwaterJ.B.MargolickJ.Jin. Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr2001; 27: 168–175.
13. A.R.LifsonE.M.KrantzL.E.Eberly. Long-term CD4+ lymphocyte response following HAART initiation in a U.S. military prospective cohort. AIDS Res Ther2011; 8: 2–6405-8-2.
14. M.M.SantoroD.ArmeniaC.Alteri. Impact of pre-therapy viral load on virological response to modern first-line HAART. Antivir Ther2013; 18: 867–876.
15. World Health Organization, UNICEF, UNAIDS. Global update on HIV treatment 2013: results, impact and opportunities – Summary, Switzerland: World Health Organization, 2013.
16. A.MocroftA.N.PhillipsJ.Gatell. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet2007; 370: 407–413.
17. J.J.LokR.J.BoschC.A.Benson. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS2010; 24: 1867–1876.
18. W.S.WongA.W.LoL.P.Siu. Reference ranges for lymphocyte subsets among healthy Hong Kong Chinese adults by single-platform flow cytometry. Clin Vaccine Immunol2013; 20: 602–606.
19. W.S.ClevelandS.J.Devlin. Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc1988; 83: 596–610.
20. W.G.Jacoby. Loess: a nonparametric, graphical tool for depicting relationships between variables. Elect Stud2000; 19: 577–613.
21. K.M.KamW.L.LeungM.Y.Kwok. Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin Diagn Lab Immunol1996; 3: 326–330.
22. K.Jentsch-UllrichM.KoenigsmannM.Mohren. Lymphocyte subsets’ reference ranges in an age- and gender-balanced population of 100 healthy adults – a monocentric German study. Clin Immunol2005; 116: 192–197.
23. Y.LebranchuG.ThibaultD.Degenne. Abnormalities in CD4+ T lymphocyte subsets in patients with common variable immunodeficiency. Clin Immunol Immunopathol1991; 61: 83–92.
24. K.H.WongK.C.ChanS.S.Lee. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis2004; 39: 853–60.
25. D.D.TaubD.L.Longo. Insights into thymic aging and regeneration. Immunol Rev2005; 205: 72–93.
26. J.A.BartlettM.J.FathR.Demasi. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS2006; 20: 2051–2064.